Envarsus Pa 0.75 mg

ENVARSUS PA 0.75 MG is an extended-release tablet containing tacrolimus, used for immunosuppression. It helps prevent organ rejection post-transplant. Learn more about its uses and effects.

ENVARSUS PA 0.75 MG is primarily used to prevent organ rejection in transplant patients. Tacrolimus works by suppressing the immune system, allowing the body to accept the transplanted organ. This medication is often prescribed for kidney, liver, or heart transplants. It is important to follow your healthcare provider's instructions when using this drug.

Common effects of ENVARSUS PA 0.75 MG may include headaches, tremors, and increased blood pressure. Some users might experience gastrointestinal issues like nausea or diarrhea. These effects vary among individuals and are not exhaustive. Always consult your healthcare provider for personalized advice.

ENVARSUS PA 0.75 MG should be handled with care. Store it at room temperature away from moisture and heat. Do not crush or chew the extended-release tablets. Follow your healthcare provider's instructions for administration. Inform your healthcare provider about any allergies or other medications you are taking.

ENVARSUS PA 0.75 MG may interact with other medications, including certain antibiotics, antifungals, and heart medications. It is important to avoid grapefruit and grapefruit juice, as they can affect how your body processes tacrolimus. Always inform your healthcare provider about all the medications you are taking to avoid potential interactions.